You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
A Theranos whistleblower watched all three hours of “You Can See Everything,” so you don’t have to. Send news tips and boring truths about liars to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
The need-to-know this week
Elevance Health holds its third-quarter earnings call on Wednesday.
On Thursday, KFF will release its annual Employer Health Benefits Survey, which will provide insights on premiums, deductibles, and cost-sharing.
Also Thursday, a federal court will hear arguments in Commonwealth of Massachusetts v. Oz, a lawsuit brought by 25 states and D.C. challenging the Trump administration’s implementation of new Medicaid work requirements.
What’s in a name?
FDA officials seem to be reviving a policy to ensure that drugs are tested on their intended patient populations.